Brief: Tourmaline Bio To Receive Termination Fee Of $68.5 Million If Merger Terminated - SEC Filing
Sept 9 (Reuters) - Tourmaline Bio Inc TRML.O: TOURMALINE BIO: NOVARTIS REQUIRED TO PAY TERMINATION FEE OF $68.5 MILLION TO CO UNDER CERTAIN SPECIFIED CIRCUMSTANCES, IF MERGER TERMINATED - SEC FILING TOURMALINE BIO: IF DEAL IS TERMINATED UNDER SOME CIRCUMSTANCES, CO TO PAY FEE OF $48 MILLION TO NOVARTIS AG Source text: [ID:n0001193125-25-198747] Further company coverage: TRML.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy